Smith & Nephew PLCSN
Mentioned
Impact on assets 2
Aging Population
Smith & Nephew PLCConsumer Discretionary
SharkNinja, Inc.SN
Mentioned
Smith & Nephew PLCSharkNinja, Inc.Smith+Nephew has announced that its CARTIHEAL AGILI-C cartilage repair implant is now commercially available in Europe, following its U.S. introduction in 2024. The implant, made of aragonite, a natural form of calcium carbonate that acts as a biphasic scaffold, is designed to repair cartilage, restore bone and relieve pain, and will be featured at the International Cartilage Regeneration & Joint Preservation Society Congress in Porto, Portugal, from October 8 to 10. A multicenter randomized clinical trial published in the American Journal of Sports Medicine found that the CARTIHEAL AGILI-C implant achieved superior overall KOOS scores compared with standard surgical treatment at all time points evaluated through 60 months of follow-up, with greater pain relief and functional improvement at 2, 4 and 5 years and no statistically significant difference in clinical outcomes between patients with and without osteoarthritis. Joaquín Lasso, Senior Vice President and International General Manager of Sports Medicine at Smith+Nephew, said the European launch offers surgeons an innovative, evidence-backed solution for cartilage repair. The implant will launch initially in Austria, Belgium, France, Germany, Ireland, Italy, Luxembourg, the Netherlands, Portugal, Spain, Switzerland and the United Kingdom, with expansion to other countries expected shortly after.
Smith & Nephew PLCSharkNinja, Inc.